XWELL, Inc. (NASDAQ:XWEL – Get Free Report)’s share price rose 7.3% during trading on Wednesday. The stock traded as high as $0.8012 and last traded at $0.7008. 167,062 shares traded hands during trading, an increase of 223% from the average session volume of 51,692 shares. The stock had previously closed at $0.6530.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company has a consensus rating of “Sell”.
Read Our Latest Research Report on XWEL
XWELL Stock Down 0.2%
The firm has a market cap of $6.80 million, a PE ratio of -0.13 and a beta of 0.93. The company’s fifty day moving average price is $0.89 and its two-hundred day moving average price is $1.08.
XWELL (NASDAQ:XWEL – Get Free Report) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.00) by $0.74. XWELL had a negative net margin of 82.90% and a negative return on equity of 1,091.48%. The firm had revenue of $7.15 million during the quarter, compared to analysts’ expectations of $2.37 million.
About XWELL
XWELL Corporation (NASDAQ: XWEL) is a health and wellness company that operates services designed to support relaxation, recovery and personal well-being. The company is best known for XpresSpa, an airport-based wellness brand offering services such as massages, facials, nail care and other spa treatments to travelers.
XWELL also has experience in health-related services and healthcare technology. Its XpresCheck business provided COVID-19 testing and related health services at select airports during the pandemic, while HyperPointe provides digital marketing, data and technology services to healthcare and life sciences organizations.
The company was formerly known as XpresSpa Group and adopted the XWELL name in 2023 to reflect its broader focus on wellness and healthcare-related businesses.
Further Reading
- Five stocks we like better than XWELL
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.
